History
Research marketplaces make it possible for scientists to use contract research organizations (CROs) to outsource an entire pharmaceutical drug discovery project without requiring physical access to a laboratory. [8] [9] [10] [11] [12] The company has been referred to as the “Amazon.com for medical research,” “A Home Depot for science and medicine” and the “EBay for drug discovery services." [2] [7] [13] [14] In 2011 and 2012, Scientist.com launched outsourcing marketplaces for the large pharmaceutical companies Pfizer and AstraZeneca, respectively. [1] [15] [16] [17] [18] [19] The marketplace was featured in a 2012 TEDMED talk given by then-Stanford University professor Atul Butte. [14] [20] In 2013, the company launched a private academic marketplace for the National Cancer Institute. [21] By June 2016, when the company rebranded as Scientist.com, it operated private research marketplaces for 10 pharmaceutical companies and the US National Institutes of Health. [21] [22] In 2017, Scientist.com rolled out a series of new marketplace features to attract more customers, including COMPLi®, a comprehensive process that oversees the sourcing of regulated services for scientific research, such as the legal and ethical acquisition of biological specimens, animal welfare, toxicology studies, secondary real world evidence (RWE), health economics and outcomes research (HEOR), and GxP services. [23] [24] [25] By the end of 2017, the company operated private marketplaces for most of the world's major pharmaceutical companies and entered into a collaboration with VWR International to create an end-to-end research solution. [26]
In 2018, Scientist.com launched DataSmart, a platform to ensure data integrity; DataSmart is based on proprietary blockchain technology developed by Scientist.com. [27] [28] [29] The company also opened an office in Tokyo, Japan in 2018 in order to work more closely with Japanese pharma companies. [30] [31] In 2019, Scientist.com unveiled its first original service offering, Trial Insights, a digital reporting platform that aggregates publicly available clinical trials data into usable online dashboards. [32] Later in 2019, Scientist.com launched SciPay, an early-payment program for the thousands of registered suppliers on its marketplace. [33] In late 2020, Scientist.com acquired HealthEconomics.Com, the world's leading ConnectedCommunity in the Value, Evidence and Access space. [34] Then, in 2021, Scientist.com completed three additional acquisitions, one of which was InsideScientific, an online environment that facilitates the exchange of scientific information via webinars, podcasts, and more. [35] Next, was Notch8, which provides software and app development services, and have since rebranded as Scientist.com Software Solutions. [36] Lastly, is BioPharmCatalyst, an online resource for stock market investors of publicly traded biotech and pharmaceutical companies listed on U.S. markets (NASDAQ and NYSE). [37]
By 2021, Scientist.com evolved from the pharmaceutical industry’s leading research marketplace into a procurement orchestration platform. Additionally, that year Scientist.com launched its AI-powered Tumor Model Finder, a solution that enables researchers to quickly find suitable preclinical models to accelerate their cancer research. The company expanded significantly in 2022 with the launch of the Product Hub [38] , giving researchers access to over 15 million research reagents, consumables, and lab supplies. The following year, the company developed the Supplier Intelligence Portal, which leverages $2 billion in historical data to provide deep insights into supplier performance and capabilities.
In 2024, the company introduced Elisa [39] , a private AI chatbot tailored for biopharma researchers to manage complex tasks like price negotiations, study completion timelines and more. Most recently is the launch of Procurement CoPilot™, a tool powered by Generative AI that simplifies sourcing workflows through guided buying features and a flexible billing model. Today, Scientist.com has evolved from simply a marketplace to a strategic innovation partner, supporting biopharma researchers worldwide with their procurement orchestration solutions. In 2025, Scientist.com was acquired by GHO Capital Partners LLP, a specialist private equity investor in global healthcare.
This page is based on this
Wikipedia article Text is available under the
CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
